Titan Pharmaceuticals upgraded by Maxim Group with a new price target
$TTNP
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
Maxim Group upgraded Titan Pharmaceuticals from Hold to Buy and set a new price target of $11.00
Save time and jump to the most important pieces.
3 - TITAN PHARMACEUTICALS INC (0000910267) (Issuer)
3 - TITAN PHARMACEUTICALS INC (0000910267) (Issuer)
3 - TITAN PHARMACEUTICALS INC (0000910267) (Issuer)